CareDx, Inc. v. Natera, Inc., No. 22-1027 (Fed. Cir. July 18, 2022)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

CareDx, Inc. and The Board of Trustees of the Leland Stanford Junior University (“Stanford”) (collectively, “CareDx”) appeal from a decision of the United States Dis- trict Court for the District of Delaware holding that U.S. Patents 8,703,652 (the “’652 patent”), 9,845,497 (the “’497 patent”), and 10,329,607 (the “’607 patent”) are ineligible for patent under 35 U.S.C. § 101. See CareDx, Inc. v. Natera, Inc. , 563 F. Supp. 3d 329 (D. Del. 2021) (“ Deci- sion”). We affirm. CAREDX, INC. v. NATERA, INC.